Genkyotex’s setanaxib shows favourable safety profile in Phase I trial
French biopharmaceutical firm Genkyotex has reported positive data from the Phase I trial of its lead product candidate, setanaxib (GKT831),…
19 Jan 2021
Debiopharm begins Phase II trial of alisporivir against Covid-19 in France
Swiss biopharmaceutical firm Debiopharm has started the dosing of the first patient in a Phase II proof-of-concept clinical trial of its antiviral alisporivir (Debio 025) for treating hospitalised Covid-19 patients.…
19 Jan 2021
Grifols to initiate new Covid-19 drug trial in Spain
Grifols is set to initiate a clinical trial in Spain to analyse a new Covid-19 drug, which can potentially offer immediate post-exposure protection against the SARS-CoV-2 virus. An anti-SARS-CoV-2 immunoglobulin,…
18 Jan 2021
Seelos Therapeutics begins dosing in study of SLS-002
Clinical-stage biopharma firm Seelos Therapeutics has dosed the first patients in its registrational 'Proof of Concept' study to evaluate SLS-002 (intranasal racemic ketamine) for acute suicidal ideation and behaviour in…
18 Jan 2021
Dr Reddy’s receives DCGI approval for trial of Sputnik V vaccine in India
Dr Reddy’s Laboratories is all set to conduct a Phase III clinical trial of the Covid-19 vaccine, Sputnik V, after it received approval from the Drugs Control General of India…
18 Jan 2021
Cyxone screens first patient in Phase II Covid-19 trial
Cyxone has announced the screening of the first participant in the Phase II clinical trial to evaluate Rabeximod for treating Covid-19 patients. The trial is analysing the efficacy and safety…
15 Jan 2021
Mirum initiates enrolment in Phase IIb VISTAS study of volixibat for PSC
Mirum Pharmaceuticals has enrolled the first patient in its Phase IIb VISTAS study of volixibat in adult patients with primary sclerosing cholangitis (PSC), an idiopathic chronic cholestatic liver disease. An…